-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Emerging Genetic and Pharmacologic Therapies for Controlling Hemostasis

Program: Education Program
Session: Challenges in Hemophilia Care
Sunday, December 6, 2015, 9:30 AM-11:00 AM
W307, Level 3 (Orange County Convention Center)
Monday, December 7, 2015, 10:30 AM-12:00 PM
W304EFGH, Level 3 (Orange County Convention Center)

Paul E. Monahan, MD

Department of Pediatrics and Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; Pediatrics, Harold R. Roberts Comprehensive Hemophilia Treatment Center, Gene Therapy Center, University of North Carolina, Chapel Hill, NC

Disclosures: Monahan: Baxter/Baxalta: Consultancy , Honoraria , Research Funding ; Chatham LLC: Consultancy ; CSL Behring: Consultancy , Honoraria ; Pfizer: Honoraria ; Novo Nordisk: Consultancy , Honoraria , Research Funding ; Bayer: Consultancy ; Asklepios BioPharmaceutical: Consultancy , Patents & Royalties: Author I.P. licensed by UNC to AskBio , Research Funding ; Prolor: Research Funding . Off Label Use: The drugs that will be discussed are investigational agents, are not licensed therapies, and have not been assigned label indications..

See more of: Challenges in Hemophilia Care
See more of: Education Program
<< Previous Presentation | Next Presentation >>